Aktuelles für Forschende
- Worth knowing
- Events
- Internal Calls
- External Calls
-
Worth knowing
Groningen/UHH- Seed Funding, application deadline: 08/11/2026
University of Hamburg and the University of Groningen jointly provide seed funding to support promising collaborative initiatives that aim to enhance collaboration and connectivity in research, teaching, student activities, and other general cooperative efforts. You are invited to apply for funding up to a maximum of EUR 4,000. The initiative will be jointly funded by the University of Hamburg and the University of Groningen. Funding will be confirmed in December and should be spent within 12 months starting from 1 January 2027. Visit the website for further information and to access the proposal template.Patiententag aus Anlass der Jahrestagung der Europäischen Gesellschaft für Gen- und Zelltherapie in Hamburg, 26/10/2026, 17:00 Uhr - 20:45 Uhr
Der Patiententag richtet sich an Patient:innen, Angehörige sowie Interessierte und wird von der Deutschen Gesellschaft für Gen- und Zelltherapie (DG-GZT) mit Unterstützung des Deutschen Zentrums für Kinder- und Jugendgesundheit (DZKJ) organisiert. Das kostenfreie Programm und den Link zur Anmeldung finden Sie hier .
Darüber hinaus wird der Zugang zum Kongress der Europäischen Gesellschaft für Gen- und Zelltherapie am Freitag den 30.10.26 für Student:innen kostenfrei sein. Hierfür ist nur eine Anmeldung am Registration Desk notwendig sein, um ein Badge zu erhalten.Call for Abstracts for EUGLOH Global Health Forum 2027 in Munich
Taking place at Ludwig-Maximilians-Universität München from 16 to 18 March 2027, the EUGLOH Global Health Forum 2027 – “Future-Proofing Global Health: Health Security for Today and Tomorrow, for All” will bring together scientists from European universities and beyond to foster dialogue, collaboration, and interdisciplinary approaches to global health. Those interested in contributing to program are invited to submit an abstract (poster, 10-minute oral presentation, 60- or 90-minute workshop). The call for abstracts is open until 31 October 2026. The LMU Global Health Day Team may be contacted for questions at ARB.GlobalHealthDay@med.uni-muenchen.de, along with the UHH EUGLOH team at eugloh@uni-hamburg.de. Find out more and submit an abstract by 31 October 2026 here .Scientific Symposium marking the 15th anniversary of the UKE Microscopy Imaging Facility (umif), 10/11/2026
The UKE Microscopy Imaging Facility (UMIF) is a widely recognized core facility for light microscopy in Germany. Its particular strength lies in the development and establishment of new tools for super-resolution light microscopy and their application in biomedical imaging. This success is largely driven by the productive exchange between the facility’s users and its staff, as well as by the shared commitment of everyone involved. On November 10, we will celebrate the 15th anniversary of the UMIF. As part of the celebration, three outstanding scientists will present their work. Nobel laureate Stefan Hell (Max Planck Institute for Multidisciplinary Sciences, Göttingen) will begin by discussing powerful imaging techniques that enable the investigation of phenomena at the molecular level. This will be followed by Catherine Meyer-Schwesinger and Stefan Lechner from UKE, who will show how super-resolution microscopy has become an integral part of their groundbreaking biomedical research. The event will conclude with a small buffet, giving us an opportunity to celebrate what we have achieved together (programme in appendix 3). Please register until 02/11/2026 here .Scientific Speed Dating for early career scientists, 17/11/2026
For the fourth time, the Dean’s Office for Research invites all UKE late-stage PhD students, postdoctoral researchers, and clinician scientists to its Scientific Speed Dating event. If you are in search of new ideas and impulses and would like to connect with fellow UKE researchers from various discipline, then you should sign up for the Scientific Speed Dating event on Tuesday 17 November, from 5-7 pm. Get in touch with each other in casual 5-minute chats and explore what the person opposite you is involved in scientifically or clinically. Take the time to enjoy a free pizza and you can figure out how to best connect your research and how your future work can benefit from your new contacts. Please contact us at explore@uke.de if you are interested to participate.Aurora Seminar with Cytek, 19/11/2026
The Cytometry and Cell Sorting Core Facility is pleased to invite you to an Aurora Seminar with Dr. Sebastian Thalmann from Cytek, focusing on spectral flow cytometry using the Cytek Aurora system. The seminar will take place on November 19, 2026, in N25, Ground Floor, Seminar Room 0.01. The program includes a beginner’s course from 9:00-11:00 AM, a break from 11:00 AM-12:00 PM, an advanced user course from 12:00-2:00 PM, and a troubleshooting course from 2:00-3:00 PM for everyone interested in spectral flow cytometry on an Aurora system. Please register via facs@uke.de.International Postdoc Lunch – Next meet-up: 01/12/2026
The Dean’s office warmly invites all international postdocs to join the next International Postdoc Lunch. This informal gathering offers a great opportunity to meet fellow researchers from diverse backgrounds, get to know one another, exchange ideas and experiences, and build connections across departments and disciplines. Whether you are new to the UKE or have been here for some time, everyone is very welcome. We will meet at the table tennis table in front of building N55 before heading to the canteen together for lunch on Tuesday, 1st December at 12:30 pm. We look forward to seeing you there!Use & Access to data from the German National Cohort (NAKO)
The NAKO Gesundheitsstudie (NAKO, German National Cohort) is Germany's largest and most comprehensive population-based cohort study and offers a huge health research resource, including biospecimen, for your own scientific questions. The strength of NAKO is the characterization of more than 200,000 participants aged 20 to 69 years by repeated medical examinations prior to, during and after the onset of disease, thereof 10,000 in the UKE. This enables an assessment of longitudinal health trajectories and the identification of early subclinical changes. NAKO allows the integrated evaluation of biological, societal, environmental, and individual determinants of health and disease. To find out more about data availability and the application process, please see attachment 3 and register on the NAKO Transfer Hub, where you find a new Tutorial on how to get access step by step. For more information and questions contact Dr. Nadia Obi ( n.obi@uke.de) .
Aktuelle Pressemitteilungen aus dem Bereich der Forschung
04.09.2026
Norddeutscher Wissenschaftspreis für Forschungsverbund DEEP-DV
Für seine länderübergreifende Zusammenarbeit hat der Forschungsverbund DEEP-DV („Disrupt – Evade – Exploit: Genexpression und Manipulation der Wirtsantwort bei DNA-Virus-Infektionen“) den Norddeutschen Wissenschaftspreis 2026 erhalten.
Zur Pressemitteilung03.09.2026
Europäischer Forschungsrat zeichnet Onkologen des UKE mit ERC Starting Grant aus
Im UKE forscht Dr. Joseph Tintelnot über das körpereigene Immunsystem im Kontext von Krebs. Für sein Projekt „TIMED-ICI“ wird der Onkologe jetzt mit einem ERC Starting Grant ausgezeichnet.
Zur PressemitteilungWeitere interessante Pressemitteilungen aus dem UKE, sowohl aktuelle als auch das Archiv, finden Sie auf den Seiten der Unternehmenskommunikation
-
-
Events
Veranstaltungen am UKE
.
Oktober 2026
Mo
Di
Mi
Do
Fr
Sa
So
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
30
31
November 2026
Mo
Di
Mi
Do
Fr
Sa
So
1
2
3
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
22
23
25
26
29
30
Dezember 2026
Mo
Di
Mi
Do
Fr
Sa
So
1
2
3
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
-
Internal Calls
Zur Zeit keine Ausschreibungen
-
External Calls
DFG-Nachwuchsakademie „TransFER-Hämotherapeutische Forschung“, Bewerbungsfrist: 30/11/2026
Die DFG fördert die Einrichtung der Nachwuchsakademie „TransFER – Hämotherapeutische Forschung“. Bis zu 20 Wissenschaftler*innen in frühen Karrierephasen sollen im Rahmen eines individuellen Mentoringprogramms und einer einwöchigen Akademiewoche ihren ersten eigenen DFG-Antrag entwickeln und sich für eine eigenständige wissenschaftliche Laufbahn qualifizieren. Weitere Informationen.Novartis Foundation for Therapeutic Research, application deadline: 21/12/2026
As part of its statutory mission, the Foundation for Therapeutic Research supports medical and scientific research projects with funding of up to €100,000 per project. The maximum funding period for a project is three years. The funding programme is specifically intended to support industry-independent research initiatives. The focus is on projects that are not associated with pharmaceutical industry-initiated studies, particularly pivotal clinical trials conducted at German research centres, but rather on independently developed scientific research projects. The Novartis Foundation is inviting applications for funding in the field of therapeutic research in 2026 under the following topic: “Infectious Diseases & Antimicrobial Resistance:
Urgent Need for New Therapeutic Agents and Technologies”. More information .PRISM - first open call for paediatric clinical studies, Letter of Intent deadline: 31/12/2026
The EU-funded PRISM (Paediatric clinical Research Infrastructure Service Model) consortium has launched its first Transnational Access call (TNA1) to support paediatric multinational investigator-initiated clinical studies . This initiative aims to bridge operational and regulatory gaps by offering coordinated, end-to-end trial management services. Projects across all disease areas, with the exception of cancer and rare diseases, can include pragmatic comparative effectiveness trials, optimization studies, drug repurposing trials, or observational studies. Selected projects will receive funding to cover the costs of research and trial coordination, as well as multinational trial management services provided by the PRISM consortium. Eligible applicants include non-commercial, experienced sponsors based in Europe (EU, Norway, Switzerland, UK) or Canada. For further information and advice, contact Katharina Lötzer from the EU team.
ERC Consolidator Grant 2027 call now open, Deadline: 12/01/2027
The ERC Consolidator Grant 2027 call is now open. ERC Consolidator Grants support established researchers who want to consolidate their independence by establishing or strengthening their research team. Applicants are eligible if they defended their PhD between 5 and 15 years prior to 1 January 2027 (extensions can be granted under certain circumstances). A promising project idea from any discipline can be proposed and the only evaluation criterion is scientific excellence. Projects can have a duration of up to five years, with a maximum funding of € 2 million (additional funding can be applied for). mERCury, the European network of ERC National Contact Points, is hosting the online event “Towards an ERC Consolidator Grant: from promising idea to competitive proposal” on 30 October from 10:00 to 12:40 CET. For further information and advice, contact t Katharina Lötzer from the EU team.re-announcement: ERA4Health JTC 2027 on multi-national Investigator-Initiated Clinical Studies; Pre-proposal deadline: 14/01/2027
The European Partnership ERA4Health has pre-announced its 9th joint transnational call, “IICS4all 2027” , expected to be launched on 27 October 2026. The aim of the call is to support pragmatic, phase III, randomised controlled, multi-national interventional Investigator-Initiated Clinical Studies with a focus on comparative-effectiveness studies as well as drug repurposing studies of off-patent drugs. The call addresses diseases of high public relevance in the areas of cardiovascular diseases, metabolic disorders, autoimmune diseases, and non-communicable respiratory diseases. Studies must ensure inclusivity and diversity in the study population. An online info session for applicants will be held on 10 November 2026. For further information and advice, contact Katharina Lötzer from the EU team.DFG-Nachwuchsakademie „Gefäßchirurgie- von der Bench bis zur klinischen Forschung“, Bewerbungsfrist: 20/01/2027
Die Gefäßchirurgie hat sich in den vergangenen Jahrzehnten zu einem hochspezialisierten Fachgebiet entwickelt. Während die Entwicklung neuer operativer und endovaskulärer Verfahren lange Zeit im Mittelpunkt stand, werden heute zunehmend hochwertige klinische Studien, translational orientierte Forschungsansätze sowie innovative Technologien benötigt, um bestehende Therapien weiterzuentwickeln und neue Behandlungsstrategien zu etablieren. Die Nachwuchsakademie soll dazu beitragen, eine neue Generation wissenschaftlich aktiver Gefäßchirurg:innen auszubilden, nationale Forschungsnetzwerke zu stärken und die Wettbewerbsfähigkeit der deutschen Gefäßchirurgie in der öffentlichen Forschungsförderung nachhaltig zu verbessern. Weitere Informationen.Update on the Horizon Europe Health calls 2027, First Deadlines: 17/02/2027
The European Commission has published an amended version of the Horizon Europe 2026-2027 Health Work Programme . The new opening dates and deadlines for the 2027 Horizon Europe Health calls are now officially confirmed. Forthcoming calls: HORIZON-HLTH-2027-01 - 10 topics (single-stage), opening date: 29 October 2026 - deadline: 17 February 2027 | HORIZON-HLTH-2027-02 - 4 topics ( two-stage), opening date: 29 October 2026 - deadlines: 17 February 2027 (stage 1) and 16 September 2027 (stage 2) | HORIZON-HLTH-2027-03 - 3 topics (single-stage), opening date: 03 June 2027 – deadline: 16 September 2027. Safe the date: The European Commission will host the online Horizon Europe Health Info Day on 26 November 2026. Ahead of this, the Network of National Contact Points Health (HNN 3.0) is organizing an online brokerage event from 24 to 25 November 2026. For further information and advice, contact Katharina Lötzer from the EU team.
Aktuelle Ausgabe „wissen + forschen“ zum Thema Visionäre Medizinforschung
Die Medizin der Zukunft hat - auch wenn der erste Eindruck es glauben macht - nichts mit unendlichen Weiten und fernen Galaxien zu tun. Zur Präzisionsmedizin gehört die CAR-T-Zelltherapie, die bereits seit 2019 erfolgreich im UKE angewandt wird. Dabei wird das Immunsystem mobilisiert, sich gegen bösartige Krebszellen zu wehren. Unterm Mikroskop sieht die Auseinandersetzung wie ein Geschehen im Weltraum aus. Die Immuntherapie ist ein Beispiel für die Medizin der Zukunft, an der im UKE intensiv geforscht wird. Weitere finden Sie hier und in der neuen Ausgabe unseres Magazins wissen+forschen.
Bei Fragen zum Seiteninhalt wenden Sie sich bitte an Frau Dr. A. Wulf ( a.wulf@uke.de )